Northwest & Ethical Investments’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $27.2M | Sell |
125,114
-11,591
| -8% | -$2.57M | 0.63% | 44 |
|
|
2025
Q4 | $31.2M | Sell |
136,705
-8,373
| -6% | -$1.91M | 0.7% | 35 |
|
|
2025
Q3 | $33.5M | Buy |
145,078
+26,285
| +22% | +$5.35M | 0.79% | 25 |
|
|
2025
Q2 | $22M | Sell |
118,793
-34,522
| -23% | -$6.42M | 0.55% | 58 |
|
|
2025
Q1 | $32.1M | Sell |
153,315
-42,135
| -22% | -$8.19M | 0.87% | 21 |
|
|
2024
Q4 | $34.7M | Buy |
195,450
+6,375
| +3% | +$1.17M | 0.94% | 15 |
|
|
2024
Q3 | $37.3M | Buy |
189,075
+10,937
| +6% | +$2.04M | 0.99% | 15 |
|
|
2024
Q2 | $30.6M | Sell |
178,138
-312
| -0.2% | -$51.7K | 0.88% | 21 |
|
|
2024
Q1 | $32.5M | Buy |
178,450
+31,461
| +21% | +$5.42M | 0.94% | 20 |
|
|
2023
Q4 | $22.8M | Sell |
146,989
-187
| -0.1% | -$27.3K | 0.7% | 39 |
|
|
2023
Q3 | $21.9M | Sell |
147,176
-41,697
| -22% | -$6.12M | 0.74% | 34 |
|
|
2023
Q2 | $25.4M | Buy |
188,873
+42,294
| +29% | +$6.2M | 0.82% | 30 |
|
|
2023
Q1 | $23.4M | Buy |
146,579
+1,480
| +1% | +$226K | 0.78% | 32 |
|
|
2022
Q4 | $23.4M | Buy |
145,099
+32,952
| +29% | +$5.05M | 0.81% | 31 |
|
|
2022
Q3 | $15.1M | Sell |
112,147
-338
| -0.3% | -$48.5K | 0.6% | 46 |
|
|
2022
Q2 | $17.2M | Buy |
112,485
+23,097
| +26% | +$3.53M | 0.65% | 44 |
|
|
2022
Q1 | $14.5M | Buy |
89,388
+114
| +0.1% | +$16.6K | 0.46% | 67 |
|
|
2021
Q4 | $12.1M | Buy |
89,274
+50,135
| +128% | +$5.92M | 0.36% | 85 |
|
|
2021
Q3 | $4.22M | Buy |
39,139
+27,492
| +236% | +$3.14M | 0.14% | 178 |
|
|
2021
Q2 | $1.31M | Sell |
11,647
-24,346
| -68% | -$2.74M | 0.04% | 277 |
|
|
2021
Q1 | $3.9M | Sell |
35,993
-1,781
| -5% | -$191K | 0.14% | 188 |
|
|
2020
Q4 | $4.05M | Sell |
37,774
-2,575
| -6% | -$247K | 0.15% | 173 |
|
|
2020
Q3 | $3.53M | Sell |
40,349
-10,118
| -20% | -$953K | 0.16% | 165 |
|
|
2020
Q2 | $4.95M | Buy |
50,467
+16,111
| +47% | +$1.42M | 0.23% | 129 |
|
|
2020
Q1 | $2.62M | Buy |
34,356
+1,731
| +5% | +$147K | 0.15% | 175 |
|
|
2019
Q4 | $2.89M | Sell |
32,625
-459
| -1% | -$38.1K | 0.13% | 207 |
|
|
2019
Q3 | $2.51M | Buy |
+33,084
| New | +$2.27M | 0.12% | 217 |
|
|
2018
Q4 | – | Sell |
-23,305
| Closed | -$2.2M | – | 364 |
|
|
2018
Q3 | $2.2M | Hold |
23,305
| – | – | 0.14% | 212 |
|
|
2018
Q2 | $2.16M | Sell |
23,305
-14,992
| -39% | -$1.46M | 0.14% | 204 |
|
|
2018
Q1 | $3.62M | Sell |
38,297
-21,871
| -36% | -$2.4M | 0.24% | 127 |
|
|
2017
Q4 | $5.82M | Sell |
60,168
-16,424
| -21% | -$1.55M | 0.38% | 67 |
|
|
2017
Q3 | $6.81M | Sell |
76,592
-29
| -0% | -$2.21K | 0.42% | 56 |
|
|
2017
Q2 | $5.56M | Sell |
76,621
-23,000
| -23% | -$1.55M | 0.38% | 62 |
|
|
2017
Q1 | $6.49M | Buy |
99,621
+2,483
| +3% | +$156K | 0.44% | 47 |
|
|
2016
Q4 | $6.08M | Sell |
97,138
-14,162
| -13% | -$864K | 0.42% | 52 |
|
|
2016
Q3 | $7.02M | Buy |
+111,300
| New | +$7.21M | 0.49% | 45 |
|
Other funds holding ABBV
VCM
VPM
Northwest & Ethical Investments's ABBV Position: Q1 2026 in Review
Northwest & Ethical Investments reduced its AbbVie (ABBV) stake by 8.5% in Q1 2026, selling an estimated $2.57M and leaving 125,114 shares worth $27.2M. The position accounts for 0.63% of the portfolio, ranked #44.
Northwest & Ethical Investments first reported a position in ABBV in Q3 2016 and has held it in 36 quarters since. The position peaked at $37.3M in Q3 2024. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Northwest & Ethical Investments held 125,114 shares of AbbVie worth $27.2M as of Q1 2026.
- Northwest & Ethical Investments sold 11,591 AbbVie shares in Q1 2026, an estimated $2.57M.
- AbbVie made up 0.63% of Northwest & Ethical Investments's portfolio in Q1 2026, its #44 holding.
- Northwest & Ethical Investments first reported a position in AbbVie in Q3 2016 and has held it in 36 quarters since.
- Northwest & Ethical Investments's AbbVie position peaked at $37.3M in Q3 2024.
- 4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Northwest & Ethical Investments's 13F filing for Q1 2026, filed 14 May 2026.